登录新浪财经APP 搜索【信披】查看更多考评等级 *ST沪科(600608.SH)一字跌停，报3.62元，股价创6月20日以来近半年新低。*ST沪科公告称，公司于当日收到中国证券监督管理委员会下发的《立案告知 书》，因涉嫌信息披露违法违规，中国证券监督管理委员会决定对公司立案。目前公司生产经营正常，该事项不会对公司经营和管理造成重大影响。公司将 积极配合调查工作，并按照相关法律法规要求及时做好信息披露工作。(格隆汇) ...

登录新浪财经APP 搜索【信披】查看更多考评等级 近日，*ST沪科公告披露收到中国证监会《立案告知书》。公告显示，因涉嫌信息披露违法违规，根据 相关法律法规，中国证监会决定对上海宽频科技股份有限公司立案。"目前，公司各项生产经营活动正 常有序开展，上述事项不会对公司经营和管理造成重大影响。"*ST沪科称。*ST沪科投资者维权征集正 在进行中，符合条件的投资者可报名维权(详见文末)。 *ST沪科全名即上海宽频科技股份有限公司，主营业务是塑料粒子的商品贸易，兼营有色金属、食用农 产品及生产生活物资等。公司的主要产品是化工产品、农产品。 就在此次被立案消息披露不久前，*ST沪科有高管离职。据公司12月2日公告，公司董事会近日收到董 事、董事会秘书兼财务负责人云峰的书面辞职报告，云峰因个人身体原因，申请辞去公司董事、董事会 秘书兼财务负责人及子公司相关职务。 值得一提的还有，半个多月前的11月28日，*ST沪科披露的一份非经营性资金占用事项的进展公告显 示，截至11月28日，*ST沪科原控股股东南京斯威特集团有限公司及其关联方违规占用上市公司资金余 额近3.49亿元，占最近一期经审计净资产的921.63%。 所需材料 ...

公告称，目前，公司各项生产经营活动正常有序开展，上述事项不会对公司经营和管理造成重大影响。 公司将积极配合中国证监会立案调查工作，并按照有关法律法规等规定和要求，及时做好信息披露。 2025年前三季度，*ST沪科共实现营业收入544.03万元，同比下降63.7%；实现归属于上市公司股东的净 利润为106.2万元，同比增长448.84%。 12月12日晚，*ST沪科发布公告称，公司收到中国证券监督管理委员会下发的《立案告知书》。因涉嫌 信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国 证券监督管理委员会决定对公司立案。 值得一提的是，*ST沪科于11月28日晚间对外披露关于非经营性资金占用事项的进展公告。公告显示， 截至公告披露日，公司原控股股东南京斯威特集团有限公司及其关联方违规占用上市公司资金余额约为 3.49亿元，占最近一期经审计净资产的921.63%。公司拟通过公开挂牌转让所持有的南京斯威特集团及 其关联公司因历史遗留问题产生的全部债权及其他或有债权，同时解除公司全部或有负债。上述事项尚 需通过国资委备案、董事会、股东大会审议批准，并以公开挂牌转让方式实施，能否 ...

Core Viewpoint - *ST HuKe is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, which adds to the company's existing delisting risk [2][4]. Group 1: Company Status - As of December 12, *ST HuKe's stock price was 3.81 yuan, with a market capitalization of 1.253 billion yuan, reflecting a decline of 0.26% [4]. - The company has been facing delisting risks since April 30, when its stock was flagged due to negative audited profit totals and revenues below 300 million yuan [6]. - The company reported a significant decline in operating scale, with revenues dropping from 367 million yuan in 2022 to 17 million yuan in 2024 [4][6]. Group 2: Financial Performance - The company is projected to incur continuous losses, with net profits of -22.015 million yuan in 2023 and -5.6828 million yuan in 2024 [4]. - For the first three quarters of 2025, *ST HuKe's revenue was only 5.4403 million yuan, representing a year-on-year decline of 63.70%, with a non-recurring net profit of -237,200 yuan [6]. - The decline in revenue is attributed to decreased income from both chemical and agricultural product trading, as well as increased contract penalties in the agricultural sector [6].

Group 1 - The company Shanghai Broadband Technology Co., Ltd. (*ST HuKe, 600608) has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][3] - The company states that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The company is primarily engaged in the trade of agricultural and chemical products, classified under the "F51 Wholesale Industry" according to the CSRC [4] Group 2 - The company's financial performance is concerning, with a reported revenue of 1.04 million yuan in Q3 2025, a year-on-year decrease of 56.95%, and a net profit of 102.71 thousand yuan [4] - For the first three quarters of 2025, the total revenue was only 5.44 million yuan, with a net loss of 240 thousand yuan [4] - As of the end of the reporting period, the total number of shareholders was 11,676, and the company's stock price has fallen for nine consecutive trading days, closing at 3.81 yuan per share [4]

Mergers and Acquisitions - *ST Bosen has terminated the plan to sell 35% equity of Shaanxi Bosen due to failure to reach agreement on key terms [1] - Chongqing Water intends to acquire wastewater treatment project assets for 382 million yuan [2] - Rongbai Technology plans to use 342 million yuan to acquire 54.9688% of Guizhou Xinren and will increase its capital by 140 million yuan [3] - Greeenmei intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [4] Shareholding Changes - Xilong Science's major shareholder plans to reduce holdings by up to 1% [5] - Dream Lily's major shareholder intends to reduce holdings by up to 1% [6] - Jincheng Co., Ltd. plans to reduce holdings by up to 0.97% [7] Risk Matters - Bestme's actual controller has been released on bail [8] - Chaoxun Communication received a warning letter from Guangdong Securities Regulatory Commission for various issues [9] - *ST Huke has been filed for suspected violations of information disclosure [10]

Core Viewpoint - *ST沪科 has received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws, which the company claims will not significantly impact its operations and management [1][2]. Financial Performance - In the first three quarters of the year, *ST沪科 reported revenue of only 5.44 million, a year-on-year decline of 63.7%, while the net profit attributable to shareholders was 1.06 million, showing a significant increase [2]. - The company's revenue dropped sharply from 367 million in 2022 to 17.23 million in 2024, falling below 100 million [2]. - Continuous losses are expected for the years 2023 and 2024, with a risk of delisting if the total profit, net profit, or net profit after excluding non-recurring gains and losses is negative and revenue is below 300 million in 2025 [2]. Management Changes - Following the resignation of Yun Feng, the company’s board secretary and financial officer, the chairman Wang Tianyang is temporarily taking over the secretary duties, while financial manager Yang Xiuxin is acting as the financial officer [3]. - Yun Feng, who was appointed as a director in March 2024 and took on the roles of board secretary and financial officer in November, resigned due to personal health reasons after just over a year in these positions [3]. - Other significant management changes include the resignation of the chairman Zhang Lu in April and independent director Li Zheng in August, both citing personal reasons [3]. Shareholder Issues - The second-largest shareholder, Kunming Industrial Development Investment Co., Ltd., has had all its shares frozen, and the first-largest shareholder's shares are also under freeze [3]. - As of October, the former controlling shareholder, Nanjing Siweit Group Co., Ltd., and its affiliates had illegally occupied 349 million of the company's funds, accounting for 921.63% of the latest audited net assets [4].

Group 1: 恒瑞医药 - Company announced that its subsidiary received approval for clinical trials of HRS9531 injection, a novel dual agonist targeting GIPR and GLP-1R, aimed at treating metabolic dysfunction-related fatty liver disease (MASH) [1] - HRS9531 injection is expected to improve blood sugar levels and reduce weight by regulating glucose and lipid metabolism, suppressing appetite, and enhancing insulin sensitivity [1] - There are currently no similar drugs approved globally for the MASH indication, and the total R&D investment for HRS9531 has reached approximately 519 million yuan [1] Group 2: 青岛港 - Company announced the termination of its cash acquisition of 100% equity in Rizhao Port Oil Products Terminal Co., Ltd. and 50% equity in Rizhao Shihua Oil Terminal Co., Ltd. due to significant impacts from Rizhao Shihua being listed on the U.S. Specially Designated Nationals list [2] - The termination agreement was signed on December 12, 2025, and will not incur any breach of contract or other liabilities, nor will it adversely affect the company's operations or financial status [2] Group 3: 隆盛科技 - Company plans to invest approximately 350 million yuan to establish a humanoid intelligent robot innovation center in Wuxi, with a focus on R&D and industrialization of humanoid robots [3] - The project will involve a total investment of about 350 million yuan, with the company covering around 200 million yuan for land and construction, while its subsidiary will invest approximately 150 million yuan for the center's operation [3] Group 4: *ST沪科 - Company received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws [4] - The company stated that its production and operations are normal and that the investigation will not have a significant impact on its management [4] Group 5: 永鼎股份 - Company clarified that it does not directly manufacture controllable nuclear fusion devices, despite being listed as a related concept stock [5] - The revenue from its subsidiary related to this area accounts for less than 1% of the company's total revenue and is currently operating at a loss [5] - The controlling shareholder reduced its stake by 1.336 million shares during a period of abnormal stock trading [5] Group 6: 亚翔集成 - Company announced that its shareholder EVER CREATIVE reduced its stake by 414,000 shares on December 11, 2025, amid significant stock price fluctuations [6] - The stock experienced a cumulative price deviation exceeding 20% over two consecutive trading days [6] Group 7: 恩捷股份 - Company plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance and will resume trading on December 15 [8] Group 8: 芯原股份 - Company announced the termination of its plan to acquire 97% of Chipwise Technology due to discrepancies between the management's core demands and market conditions [9] - The decision was made to protect the interests of the company and its shareholders [9]

交易行情显示，12月12日，*ST沪科收跌0.26%，收于3.81元/股，总市值12.53亿元。 北京商报讯（记者 马换换 李佳雪）12月12日晚间，*ST沪科（600608）披露公告称，公司于当日收到 证监会下发的《立案告知书》，因涉嫌信息披露违法违规，证监会决定对公司立案。 *ST沪科表示，目前，公司各项生产经营活动正常有序开展，上述事项不会对公司经营和管理造成重大 影响。 ...

Group 1 - *ST Hu Ke received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws, leading to a formal case being opened against the company [2] - The company stated that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management and operations [4] - The main business of *ST Hu Ke involves the trade of agricultural and chemical products, classified under "F51 Wholesale Industry" according to the CSRC [4] Group 2 - As of December 12, *ST Hu Ke's stock price was 3.81 yuan per share, with a total market capitalization of 1.253 billion yuan [5] - Humanwell Healthcare announced that it received an administrative penalty notice from the CSRC for failing to disclose non-operating fund occupation and related transactions in its annual reports, which contained significant omissions and false records [5] - Humanwell Healthcare's stock will be subject to risk warnings starting December 16, with a daily price fluctuation limit of 5% after being placed on the risk warning board [6] Group 3 - Humanwell Healthcare, established in 1993, is a leading pharmaceutical company in Hubei Province, with a strong presence in various therapeutic areas and a comprehensive pharmaceutical value chain [8] - As of December 12, Humanwell Healthcare's stock price was 18.15 yuan per share, with a total market capitalization of 29.625 billion yuan [9]